Article Information
History
- March 19, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Zoltan Maliga1,†,
- Ajit J. Nirmal1,2,†,
- Nolan G. Ericson3,†,
- Sarah A. Boswell1,4,
- Lance U’Ren3,‡,
- Rebecca Podyminogin3,§,
- Jennifer Chow3,
- Yu-An Chen1,
- Alyce A. Chen1,
- David M. Weinstock2,
- Christine G. Lian4,
- George F. Murphy4,
- Eric P. Kaldjian3,
- Sandro Santagata1,5 and
- Peter K. Sorger1,4,*
- 1Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA
- 2Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA
- 3RareCyte Inc., 2601 4th Avenue. Suite 500, Seattle, WA 98121, USA
- 4Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA
- 5Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
- ↵*Corresponding author P.K.S. (peter_sorger{at}hms.harvard.edu) cc: alyce_chen{at}hms.harvard.edu)
↵† These authors contributed equally
Posted March 19, 2021.
